This is the cutest breast cancer email I have ever received - with a message!!
please.....
Wednesday, November 5, 2008
A Serious Message from a Baby Girl!
This is the cutest breast cancer email I have ever received - with a message!!
please.....
Wednesday, October 15, 2008
An Amazing New Glove to Detect Breast Cancer!
by Patty Donovan (NaturalNews)
October is Breast Cancer Awareness Month. The Donna Glove is a special glove designed to detect breast lumps. It provides a safe and effective way for every woman to carry out breast self examination, especially women in high risk groups. Its special design magnifies the sense of your fingers allowing lumps the size of a grain of sugar to be detected. This is not possible with bare hand palpation.You perform a breast self exam the same way, you just use the Glove instead of your bare hands. Check from your collar bone and into your armpits and do both breasts. Since lumps can grow in a week, it is suggested to perform the procedure weekly. The Donna glove helps detect lumps, thickening and other subtle changes your bare hand may not detect. Full instructions are on the website below and are provided with the glove.The glove itself is a double layer of polyurethane with mineral oil between the layers. This allows for greatly enhanced ability to feel lumps. A clinical trial in Rome proved the efficacy of the glove.108 women were studied for nearly a year. These women all had previous lumps and were at high risk for developing breast cancer. They were split into two equal groups. Group 1 was issued a Donna Glove while group 2 continued to do self breast exams with bare hands.At the 6 month follow up, 84% (45 in each group) of these patients had recurrence of the lumps confirmed by mammography. Group 1, the group issued the Donna Glove had a 100% self-detection rate. In group 2, only 22 of 45 women had detected lumps with their bare hands.The significant difference in detection rate was present even after adjusting for combinations of age, method of detection and family history of breast cancer. Mammography upheld these percentages. The study concluded that in a population of potential breast cancer patients, breast self exam with the Donna Glove is related to a greater earlier detection and thus improves survival over bare hand self examination.More information on the glove and how to order can be found here:http://www.youcanpreventcancer.com/inde...
October is Breast Cancer Awareness Month. The Donna Glove is a special glove designed to detect breast lumps. It provides a safe and effective way for every woman to carry out breast self examination, especially women in high risk groups. Its special design magnifies the sense of your fingers allowing lumps the size of a grain of sugar to be detected. This is not possible with bare hand palpation.You perform a breast self exam the same way, you just use the Glove instead of your bare hands. Check from your collar bone and into your armpits and do both breasts. Since lumps can grow in a week, it is suggested to perform the procedure weekly. The Donna glove helps detect lumps, thickening and other subtle changes your bare hand may not detect. Full instructions are on the website below and are provided with the glove.The glove itself is a double layer of polyurethane with mineral oil between the layers. This allows for greatly enhanced ability to feel lumps. A clinical trial in Rome proved the efficacy of the glove.108 women were studied for nearly a year. These women all had previous lumps and were at high risk for developing breast cancer. They were split into two equal groups. Group 1 was issued a Donna Glove while group 2 continued to do self breast exams with bare hands.At the 6 month follow up, 84% (45 in each group) of these patients had recurrence of the lumps confirmed by mammography. Group 1, the group issued the Donna Glove had a 100% self-detection rate. In group 2, only 22 of 45 women had detected lumps with their bare hands.The significant difference in detection rate was present even after adjusting for combinations of age, method of detection and family history of breast cancer. Mammography upheld these percentages. The study concluded that in a population of potential breast cancer patients, breast self exam with the Donna Glove is related to a greater earlier detection and thus improves survival over bare hand self examination.More information on the glove and how to order can be found here:http://www.youcanpreventcancer.com/inde...
Sunday, July 20, 2008
Are you at risk for breast cancer?
Anything that increases the chance of developing a disease is called a risk factor. Risk factors for breast cancer include the following:
age
age at the start of menstruation
age at first live birth
number of first-degree relatives (mother, sisters, daughters) with breast cancer
number of previous breast biopsies (whether positive or negative)
at least one breast biopsy with atypical hyperplasia
Other risk factors, such as age at menopause, dense breast tissue on a mammogram, use of birth control pills or hormone replacement therapy, a high-fat diet, drinking alcohol, low physical activity, obesity, or environmental exposures, are not included in risk estimates with the Breast Cancer Risk Assessment Tool for three reasons: evidence is not conclusive or researchers cannot accurately determine how much these factors contribute to the calculation of risk for an individual woman, or adding these factors does not increase the accuracy of the tool appreciably.
Breast cancer may also be caused by inherited gene mutations. Hereditary breast cancers account for approximately 5% to 10% of all breast cancers. Specific hereditary predispositions for breast cancer, such as inheriting a mutation in either the BRCA1 or BRCA2 gene, are not taken into account in risk estimates with the Breast Cancer Risk Assessment Tool. Although the tool performs well in clinics where women have a strong family history of breast cancer, more specific methods for projecting risk are appropriate if a woman is known to carry a breast cancer-producing mutation in BRCA1 or BRCA2.
Researchers are, however, conducting additional studies to gather more data and to determine whether including information on other risk factors can strengthen the statistical model, called the Gail model, upon which the Breast Cancer Risk Assessment Tool is based. Nonetheless, the current model estimates breast cancer risk accurately on average.
age
age at the start of menstruation
age at first live birth
number of first-degree relatives (mother, sisters, daughters) with breast cancer
number of previous breast biopsies (whether positive or negative)
at least one breast biopsy with atypical hyperplasia
Other risk factors, such as age at menopause, dense breast tissue on a mammogram, use of birth control pills or hormone replacement therapy, a high-fat diet, drinking alcohol, low physical activity, obesity, or environmental exposures, are not included in risk estimates with the Breast Cancer Risk Assessment Tool for three reasons: evidence is not conclusive or researchers cannot accurately determine how much these factors contribute to the calculation of risk for an individual woman, or adding these factors does not increase the accuracy of the tool appreciably.
Breast cancer may also be caused by inherited gene mutations. Hereditary breast cancers account for approximately 5% to 10% of all breast cancers. Specific hereditary predispositions for breast cancer, such as inheriting a mutation in either the BRCA1 or BRCA2 gene, are not taken into account in risk estimates with the Breast Cancer Risk Assessment Tool. Although the tool performs well in clinics where women have a strong family history of breast cancer, more specific methods for projecting risk are appropriate if a woman is known to carry a breast cancer-producing mutation in BRCA1 or BRCA2.
Researchers are, however, conducting additional studies to gather more data and to determine whether including information on other risk factors can strengthen the statistical model, called the Gail model, upon which the Breast Cancer Risk Assessment Tool is based. Nonetheless, the current model estimates breast cancer risk accurately on average.
Sunday, June 8, 2008
Please give a free Mammogram
Your click on the "Click Here to Give - it's FREE" button helps fund free mammograms for women in need — low-income, inner-city and minority women whose awareness of breast cancer and opportunity for help is often limited. Your click is paid for by site sponsors, and mammogram funding is provided to clinics throughout the U.S. through the efforts of the National Breast Cancer Foundation .
Early Detection: Do You Know The Facts?How You Can Help In Mere Seconds — Every Day The Breast Cancer Site provides a feel-good way to help promote awareness of breast cancer and provide free mammograms for women in need every day — through easy and quick online activities.
With a simple, daily click of the pink "Click Here to Give - it's FREE" button at The Breast Cancer Site, visitors help to provide free mammograms for women in need. Visitors pay nothing. Mammograms are provided by our charitable partners.
Please remember to click every day to fund free mammograms and give hope to women in need. Every click counts toward the goal of early detection, which allows for the best possible treatment options. Thanks to Tony Dollars and his Compassion Network blog for this tip!
Early Detection: Do You Know The Facts?How You Can Help In Mere Seconds — Every Day The Breast Cancer Site provides a feel-good way to help promote awareness of breast cancer and provide free mammograms for women in need every day — through easy and quick online activities.
With a simple, daily click of the pink "Click Here to Give - it's FREE" button at The Breast Cancer Site, visitors help to provide free mammograms for women in need. Visitors pay nothing. Mammograms are provided by our charitable partners.
Please remember to click every day to fund free mammograms and give hope to women in need. Every click counts toward the goal of early detection, which allows for the best possible treatment options. Thanks to Tony Dollars and his Compassion Network blog for this tip!
Friday, May 2, 2008
Modern Treatment for Breast Cancer
As with the treatment of similar cancers, breast cancer treatment aims to keep safe the healthy tissue while simultaneously killing the cancerous tumor at its point of origination and any other cancers that may have spread to other parts of the body. With great thanks and gratitude to researchers and medical professionals, patients suffering from breast cancer now have more options for effective treatment. Of course these options depend on several factors concerning the type, stage, and size of the tumor found. Health professionals attribute this to ground breaking research, education of the general public, and early detection initiatives.
Saturday, April 5, 2008
Chemotherapy for breast cancer can cause heart damage
Recently I was informed that a family member has sustained heart damage as a diect result of chemotherapy for breast cancer. With just a little research I came upon this article that I wanted to share with my readers:
Breast Cancer Chemotherapy Increases Heart Damage Risk
NEW YORK JAN 05, 2006 (Reuters Health) - Chemotherapy, especially anthracycline-based therapy, for breast cancer in older women increases their risk of developing cardiomyopathy.
Doxorubicin and other chemotherapeutic agents are increasingly used in the adjuvant chemotherapy of breast cancer patients, the authors explain, but long-term sequelae in such patients have received little attention.
Dr. Dawn L. Hershman from Columbia University, New York City and colleagues evaluated chemotherapy use and cardiotoxicity among 5575 women 65 years old or older in the general population diagnosed with stage I or II breast cancer.
Increasing age and black race were associated with higher rates of heart disease in these patients, the authors report, and patients with heart disease before the breast cancer diagnosis were 2.4 times more likely to experience heart disease during follow-up.
After adjusting for these factors, women who received chemotherapy had a 22% increase in the rate of heart disease, a 55% increase in the rate of cardiomyopathy, and a 20% increase in the rate of congestive heart failure, the report indicates.
The combination of radiation therapy and chemotherapy was associated with a slightly higher risk of heart disease (33%), the researchers report in the December 1st issue of the Journal of Clinical Oncology.
Among the chemotherapeutic agents used, doxorubicin was associated with the greatest increase in cardiomyopathy risk (2.5-fold), the results indicate. The incidence of cardiomyopathy in the first year after diagnosis ranged from 1.55% for women who didn't receive chemotherapy to 4.09% for women who received doxorubicin, the investigators observe.
"The elevated risk of cardiac disease associated with adjuvant chemotherapy, which has been observed among participants in clinical trials, is also present among elderly breast cancer patients in a population-based sample," the authors conclude. "Given the prevalence of anthracycline regimens in the current adjuvant breast cancer setting, some patients may benefit from increased cardiac monitoring."
SOURCE: J Clin Oncol 2005;23:8597-8605
Knowledge is power! We must inform ourselves! Hope this helps you and your loved ones!
Breast Cancer Chemotherapy Increases Heart Damage Risk
NEW YORK JAN 05, 2006 (Reuters Health) - Chemotherapy, especially anthracycline-based therapy, for breast cancer in older women increases their risk of developing cardiomyopathy.
Doxorubicin and other chemotherapeutic agents are increasingly used in the adjuvant chemotherapy of breast cancer patients, the authors explain, but long-term sequelae in such patients have received little attention.
Dr. Dawn L. Hershman from Columbia University, New York City and colleagues evaluated chemotherapy use and cardiotoxicity among 5575 women 65 years old or older in the general population diagnosed with stage I or II breast cancer.
Increasing age and black race were associated with higher rates of heart disease in these patients, the authors report, and patients with heart disease before the breast cancer diagnosis were 2.4 times more likely to experience heart disease during follow-up.
After adjusting for these factors, women who received chemotherapy had a 22% increase in the rate of heart disease, a 55% increase in the rate of cardiomyopathy, and a 20% increase in the rate of congestive heart failure, the report indicates.
The combination of radiation therapy and chemotherapy was associated with a slightly higher risk of heart disease (33%), the researchers report in the December 1st issue of the Journal of Clinical Oncology.
Among the chemotherapeutic agents used, doxorubicin was associated with the greatest increase in cardiomyopathy risk (2.5-fold), the results indicate. The incidence of cardiomyopathy in the first year after diagnosis ranged from 1.55% for women who didn't receive chemotherapy to 4.09% for women who received doxorubicin, the investigators observe.
"The elevated risk of cardiac disease associated with adjuvant chemotherapy, which has been observed among participants in clinical trials, is also present among elderly breast cancer patients in a population-based sample," the authors conclude. "Given the prevalence of anthracycline regimens in the current adjuvant breast cancer setting, some patients may benefit from increased cardiac monitoring."
SOURCE: J Clin Oncol 2005;23:8597-8605
Knowledge is power! We must inform ourselves! Hope this helps you and your loved ones!
Wednesday, March 26, 2008
Mammogram or MRI?
In Most Cases, MRI Not Indicated for Breast Cancer Screening
Q: I'm still getting yearly screening mammograms, but I heard that breast MRIs are better at detecting breast cancer and have a lower radiation level than mammograms.
Should I start getting yearly MRIs instead?
A: Breast MRIs have very limited indications and have not been approved as a screening modality for most patients.
Screening MRIs are only indicated for those who are considered very high risk. You are considered high risk if you have a known gene mutation that significantly increases the risk for breast cancer (BRCA 1 or 2), if you are a probable carrier of this gene because of family history, or if you have a calculated lifetime risk of breast cancer greater than 20-25% (this is something your doctor can calculate for you).
"For most women at high risk, screening with MRI and mammograms should begin at age 30 years and continue for as long as a woman is in good health," according to the American Cancer Society. "But because the evidence is limited regarding the best age at which to start screening, this decision should be based on shared decision making between patients and their health providers, taking into account personal circumstances and preferences."
courtesy of www.healthlink.com.
Q: I'm still getting yearly screening mammograms, but I heard that breast MRIs are better at detecting breast cancer and have a lower radiation level than mammograms.
Should I start getting yearly MRIs instead?
A: Breast MRIs have very limited indications and have not been approved as a screening modality for most patients.
Screening MRIs are only indicated for those who are considered very high risk. You are considered high risk if you have a known gene mutation that significantly increases the risk for breast cancer (BRCA 1 or 2), if you are a probable carrier of this gene because of family history, or if you have a calculated lifetime risk of breast cancer greater than 20-25% (this is something your doctor can calculate for you).
"For most women at high risk, screening with MRI and mammograms should begin at age 30 years and continue for as long as a woman is in good health," according to the American Cancer Society. "But because the evidence is limited regarding the best age at which to start screening, this decision should be based on shared decision making between patients and their health providers, taking into account personal circumstances and preferences."
courtesy of www.healthlink.com.
Subscribe to:
Posts (Atom)
Posts
